• CNS Pharmaceuticals will hold its annual shareholder meeting virtually on Sept. 30, 2026.
• Shareholders will vote to elect six directors, including Rami Levin and board chair Faith L. Charles.
• Ballots also cover auditor ratification for MaloneBailey for 2026, plus an advisory vote on executive pay.
• A separate proposal seeks to expand the 2020 Stock Plan by 650,000 shares, increasing the plan’s total to 765,061 shares.
• Investors will also consider authorizing an adjournment to solicit additional proxies if needed to pass proposals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CNS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-006660), on August 21, 2026, and is solely responsible for the information contained therein.